1. Home
  2. AWRE vs AKTX Comparison

AWRE vs AKTX Comparison

Compare AWRE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • AKTX
  • Stock Information
  • Founded
  • AWRE 1986
  • AKTX N/A
  • Country
  • AWRE United States
  • AKTX United States
  • Employees
  • AWRE N/A
  • AKTX N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • AKTX Health Care
  • Exchange
  • AWRE Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • AWRE 35.2M
  • AKTX 34.7M
  • IPO Year
  • AWRE 1996
  • AKTX N/A
  • Fundamental
  • Price
  • AWRE $1.70
  • AKTX $1.12
  • Analyst Decision
  • AWRE
  • AKTX
  • Analyst Count
  • AWRE 0
  • AKTX 0
  • Target Price
  • AWRE N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • AWRE 40.3K
  • AKTX 25.4K
  • Earning Date
  • AWRE 03-11-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • AWRE N/A
  • AKTX N/A
  • EPS Growth
  • AWRE N/A
  • AKTX N/A
  • EPS
  • AWRE N/A
  • AKTX N/A
  • Revenue
  • AWRE $16,966,000.00
  • AKTX N/A
  • Revenue This Year
  • AWRE $10.98
  • AKTX N/A
  • Revenue Next Year
  • AWRE N/A
  • AKTX N/A
  • P/E Ratio
  • AWRE N/A
  • AKTX N/A
  • Revenue Growth
  • AWRE N/A
  • AKTX N/A
  • 52 Week Low
  • AWRE $1.35
  • AKTX $0.90
  • 52 Week High
  • AWRE $2.97
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 55.46
  • AKTX 44.76
  • Support Level
  • AWRE $1.55
  • AKTX $1.10
  • Resistance Level
  • AWRE $1.71
  • AKTX $1.27
  • Average True Range (ATR)
  • AWRE 0.10
  • AKTX 0.13
  • MACD
  • AWRE 0.00
  • AKTX -0.01
  • Stochastic Oscillator
  • AWRE 80.95
  • AKTX 21.54

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: